Arcutis Biotherapeutics, Inc. Quarterly Operating Margin in % from Q4 2023 to Q4 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Arcutis Biotherapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2023 to Q4 2024.
  • Arcutis Biotherapeutics, Inc. Operating Margin for the quarter ending December 31, 2024 was -65.3 %, a 83.8% increase year-over-year.
  • Arcutis Biotherapeutics, Inc. annual Operating Margin for 2024 was -65.3 %, a 83.8% increase from 2023.
  • Arcutis Biotherapeutics, Inc. annual Operating Margin for 2023 was -404 %, a 95.1% increase from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.